GILD - Company ID 0000882095
The table below shows GILEAD SCIENCES, INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | - | - | - | - | - | - |
| Short-term investments | $0.00 | $0.00 | $15.00M | $19.00M | $69.00M | - |
| Receivables | $5.01B | $5.05B | $4.74B | $5.09B | $4.78B | $4.39B |
| Inventory | $1.90B | $1.95B | $1.91B | $1.78B | $1.82B | $1.76B |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $16.55B |
| $13.95B |
| $18.64B |
| $17.87B |
| $14.72B |
| $16.90B |
| Property, plant & equipment | $5.95B | $5.83B | $5.64B | $5.50B | $5.46B | $5.42B |
| Goodwill | $8.31B | $8.31B | $8.31B | $8.31B | $8.31B | $8.31B |
| Total assets | $51.41B | $49.36B | $56.28B | $58.53B | $55.72B | $56.43B |
| Accounts payable | $934.00M | $674.00M | $645.00M | $808.00M | $582.00M | $737.00M |
| Total current liabilities | $12.00B | $11.02B | $9.48B | $12.30B | $11.19B | $12.34B |
| Long-term debt | $23.82B | $23.83B | $20.86B | $22.14B | $22.14B | $22.15B |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | $3.11B | $2.20B | $14.13B | $12.82B | $11.32B | $10.93B |
| Total equity | $13.04B | $11.83B | $23.52B | $21.54B | $19.67B | $19.16B |